Yisheng Biopharma Co., Ltd., A Biopharmaceutical Company Focusing On Research, Development, Manufacturing, Sales And Marketing Of Immunological Biologics And Vaccines, Announced That Its New Rabies Vaccine Production Facility Has Received A Pharmaceutical Gmp Certificate From The China National Medical Products Administration (Nmpa) For Production Of Its Yisheng Junan™ Product, The First Lyophilized Rabies Vaccine Without An Aluminum Adjuvant Produced In China For Medical Use.
